NMTR - 9 Meters Biopharma propelled by a series of insider buys

Sec Form 4 filings submitted by 9 Meters Biopharma (NMTR) today indicate a series of insider buys at the company. In the post-market, 9 Meters shares have added ~18.0% in reaction. The insiders of the transactions dated April 05 include the company CEO, CFO, and a director.With the purchase of 100K shares at an average price of $1.00 apiece, CEO John Temperato has raised his stake to a total of ~1.0M common stock.The purchase of 50K shares at a similar price has increased CFO Edward J Sitar’s holdings to ~179.3K common stock.Making the largest transaction, director Mark A Sirgo has added 300K company shares at an average price of $1.00 per share to raise his stake to ~1.0M common stock.With more than a two-fold rise in its share price over the past 12-month period, 9 Meters Biopharma announced capital raise of $30M last week.

For further details see:

9 Meters Biopharma propelled by a series of insider buys